This analysis identified high-confidence candidates for SEs that drive expression of IRF4, CCND2, MYC, MDM2, and CFLAR (see Fig. 3A and B for results from BC-3 and Fig. S7B and C for results from BCBL-1 and BC-1). Here, IRF4 is linked to breast cancer.